Mesenteric panniculitis: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
==Background== | ==Background== | ||
*Also known as "sclerosing mesenteritis" | *Also known as "sclerosing mesenteritis" | ||
*A rare, benign, and chronic fibrosing inflammatory disease that affects the adipose tissue of the mesentery (of the small intestine and colon)<ref>Issa I and Baydoun H. Mesenteric panniculitis: Various presentations and treatment regimens. World J Gastroenterol. 2009 Aug 14; 15(30): 3827–3830.</ref> | *A rare, benign, and chronic fibrosing inflammatory disease that affects the adipose tissue of the mesentery (of the small intestine and colon)<ref>Issa I and Baydoun H. Mesenteric panniculitis: Various presentations and treatment regimens. World J Gastroenterol. 2009 Aug 14; 15(30): 3827–3830.</ref>. | ||
*Specific cause is unknown | *Specific cause is unknown<ref>Issa I and Baydoun H. Mesenteric panniculitis: Various presentations and treatment regimens. World J Gastroenterol. 2009 Aug 14; 15(30): 3827–3830.</ref> | ||
==Clinical Features== | ==Clinical Features== | ||
| Line 11: | Line 11: | ||
==Evaluation== | ==Evaluation== | ||
*Regional increase in mesenteric fat density on abdominal CT (i.e. “misty mesentery”) | *Regional increase in mesenteric fat density on abdominal CT (i.e. “misty mesentery”) | ||
**May be confirmed by surgical biopsy | |||
==Management== | ==Management== | ||
*Supportive ED treatment | |||
*Chronic treatment includes workup of underlying etiology and consideration of medical therapy for severe/protracted disease (e.g. corticosteroids, cyclophosphamide, or azathioprine) | |||
==Disposition== | ==Disposition== | ||
*Outpatient | |||
==See Also== | ==See Also== | ||
Revision as of 16:30, 27 June 2017
Background
- Also known as "sclerosing mesenteritis"
- A rare, benign, and chronic fibrosing inflammatory disease that affects the adipose tissue of the mesentery (of the small intestine and colon)[1].
- Specific cause is unknown[2]
Clinical Features
Differential Diagnosis
Evaluation
- Regional increase in mesenteric fat density on abdominal CT (i.e. “misty mesentery”)
- May be confirmed by surgical biopsy
Management
- Supportive ED treatment
- Chronic treatment includes workup of underlying etiology and consideration of medical therapy for severe/protracted disease (e.g. corticosteroids, cyclophosphamide, or azathioprine)
Disposition
- Outpatient